Clinical Trial Update: Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of entinostat and sorafenib in patients with advanced or metastatic solid tumors or relapsed/refractory acute myeloid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia Without Maturation
• Acute Myeloid Leukemia with Maturation
• Chronic Myeloid Leukemia Blast Crisis
• Erythroleukemia
• Monoblastic Leukemia
• Monocytic Leukemia
• Myelomonocytic Leukemia

Drugs mentioned

• Entinostat (entinostat)
• Sorafenib tosylate (sorafenib tosylate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia | Phase 1 | Status: TERMINATED